APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Serialisation Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Serialisation Services Market Analysis and Forecast 2026-2032

12 August 2026186 pages

Choose your research edition.

Industry ResearchPharmaceutical Serialisation Services Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Serialisation Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Serialisation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Serialisation Services Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Serialisation Services Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Pharmaceutical Serialisation Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Serialisation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Serialisation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Serialisation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Serialisation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Serialisation Services include Movianto, UPM Pharmaceuticals, MSK Pharmalogisti, Covectra, Koerber-Pharma, Palladio Group, TraceLink, Ultimate Solutions and Clarkston Consulting, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Serialisation Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Serialisation Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Serialisation Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Serialisation Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Serialisation Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Serialisation Services revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Serialisation Services Segment by Company

Movianto

UPM Pharmaceuticals

MSK Pharmalogisti

Covectra

Koerber-Pharma

Palladio Group

TraceLink

Ultimate Solutions

Clarkston Consulting

Jones Healthcare Group

MSK Pharmalogistic

Vetter-Pharma

NextPharma Logistics

OPTEL

Central Pharma

Aphena Pharma +C581Solutions

NNE

Sharp Services

Pharmaceutical Serialisation Services Segment by Type

Barcode

QR Code

RFID

Others

Pharmaceutical Serialisation Services Segment by Application

Pharmaceutical Manufacturing

Pharmaceutical Distribution

Pharmaceutical Logistics

Pharmaceutical Serialisation Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Serialisation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Serialisation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Serialisation Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Serialisation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Serialisation Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Serialisation Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Barcode Major Player Table 3. QR Code Major Player Table 4. RFID Major Player Table 5. Others Major Player Table 6. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Manufacturing Major Player Table 8. Pharmaceutical Distribution Major Player Table 9. Pharmaceutical Logistics Major Player Table 10. Pharmaceutical Serialisation Services Industry Trends Table 11. Pharmaceutical Serialisation Services Industry Drivers Table 12. Pharmaceutical Serialisation Services Industry Opportunities and Challenges Table 13. Pharmaceutical Serialisation Services Industry Restraints Table 14. Global Pharmaceutical Serialisation Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Pharmaceutical Serialisation Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Pharmaceutical Serialisation Services Market Share by Region (2021-2026) Table 17. Global Pharmaceutical Serialisation Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Pharmaceutical Serialisation Services Market Share by Region (2027-2032) Table 19. Global Pharmaceutical Serialisation Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Pharmaceutical Serialisation Services Revenue Market Share by Players (2021-2026) Table 21. Global Pharmaceutical Serialisation Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pharmaceutical Serialisation Services Key Players Headquarters & Area Served Table 23. Global Pharmaceutical Serialisation Services Players, Product Type & Application Table 24. Global Pharmaceutical Serialisation Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Pharmaceutical Serialisation Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Pharmaceutical Serialisation Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Serialisation Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Serialisation Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Serialisation Services Revenue Market Share by Type (2021-2026) Table 31. Global Pharmaceutical Serialisation Services Revenue Market Share by Type (2027-2032) Table 32. Global Pharmaceutical Serialisation Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Serialisation Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Serialisation Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2021-2026) Table 36. Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2027-2032) Table 37. Movianto Company Information Table 38. Movianto Business Overview Table 39. Movianto Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Movianto Pharmaceutical Serialisation Services Product Portfolio Table 41. Movianto Recent Development Table 42. UPM Pharmaceuticals Company Information Table 43. UPM Pharmaceuticals Business Overview Table 44. UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio Table 46. UPM Pharmaceuticals Recent Development Table 47. MSK Pharmalogisti Company Information Table 48. MSK Pharmalogisti Business Overview Table 49. MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio Table 51. MSK Pharmalogisti Recent Development Table 52. Covectra Company Information Table 53. Covectra Business Overview Table 54. Covectra Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Covectra Pharmaceutical Serialisation Services Product Portfolio Table 56. Covectra Recent Development Table 57. Koerber-Pharma Company Information Table 58. Koerber-Pharma Business Overview Table 59. Koerber-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio Table 61. Koerber-Pharma Recent Development Table 62. Palladio Group Company Information Table 63. Palladio Group Business Overview Table 64. Palladio Group Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Palladio Group Pharmaceutical Serialisation Services Product Portfolio Table 66. Palladio Group Recent Development Table 67. TraceLink Company Information Table 68. TraceLink Business Overview Table 69. TraceLink Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. TraceLink Pharmaceutical Serialisation Services Product Portfolio Table 71. TraceLink Recent Development Table 72. Ultimate Solutions Company Information Table 73. Ultimate Solutions Business Overview Table 74. Ultimate Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio Table 76. Ultimate Solutions Recent Development Table 77. Clarkston Consulting Company Information Table 78. Clarkston Consulting Business Overview Table 79. Clarkston Consulting Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio Table 81. Clarkston Consulting Recent Development Table 82. Jones Healthcare Group Company Information Table 83. Jones Healthcare Group Business Overview Table 84. Jones Healthcare Group Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio Table 86. Jones Healthcare Group Recent Development Table 87. MSK Pharmalogistic Company Information Table 88. MSK Pharmalogistic Business Overview Table 89. MSK Pharmalogistic Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio Table 91. MSK Pharmalogistic Recent Development Table 92. Vetter-Pharma Company Information Table 93. Vetter-Pharma Business Overview Table 94. Vetter-Pharma Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio Table 96. Vetter-Pharma Recent Development Table 97. NextPharma Logistics Company Information Table 98. NextPharma Logistics Business Overview Table 99. NextPharma Logistics Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio Table 101. NextPharma Logistics Recent Development Table 102. OPTEL Company Information Table 103. OPTEL Business Overview Table 104. OPTEL Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. OPTEL Pharmaceutical Serialisation Services Product Portfolio Table 106. OPTEL Recent Development Table 107. Central Pharma Company Information Table 108. Central Pharma Business Overview Table 109. Central Pharma Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Central Pharma Pharmaceutical Serialisation Services Product Portfolio Table 111. Central Pharma Recent Development Table 112. Aphena Pharma +C581Solutions Company Information Table 113. Aphena Pharma +C581Solutions Business Overview Table 114. Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio Table 116. Aphena Pharma +C581Solutions Recent Development Table 117. NNE Company Information Table 118. NNE Business Overview Table 119. NNE Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. NNE Pharmaceutical Serialisation Services Product Portfolio Table 121. NNE Recent Development Table 122. Sharp Services Company Information Table 123. Sharp Services Business Overview Table 124. Sharp Services Pharmaceutical Serialisation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Sharp Services Pharmaceutical Serialisation Services Product Portfolio Table 126. Sharp Services Recent Development Table 127. North America Pharmaceutical Serialisation Services Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Pharmaceutical Serialisation Services Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Pharmaceutical Serialisation Services Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Pharmaceutical Serialisation Services Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Pharmaceutical Serialisation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Pharmaceutical Serialisation Services Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Pharmaceutical Serialisation Services Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Pharmaceutical Serialisation Services Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Pharmaceutical Serialisation Services Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Pharmaceutical Serialisation Services Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Pharmaceutical Serialisation Services Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Pharmaceutical Serialisation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Pharmaceutical Serialisation Services Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Pharmaceutical Serialisation Services Revenue by Country (US$ Million) & (2027-2032) Table 141. China Pharmaceutical Serialisation Services Revenue by Type (2021-2026) & (US$ Million) Table 142. China Pharmaceutical Serialisation Services Revenue by Type (2027-2032) & (US$ Million) Table 143. China Pharmaceutical Serialisation Services Revenue by Application (2021-2026) & (US$ Million) Table 144. China Pharmaceutical Serialisation Services Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Pharmaceutical Serialisation Services Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Pharmaceutical Serialisation Services Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Pharmaceutical Serialisation Services Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Pharmaceutical Serialisation Services Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Pharmaceutical Serialisation Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Pharmaceutical Serialisation Services Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Pharmaceutical Serialisation Services Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Pharmaceutical Serialisation Services Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Pharmaceutical Serialisation Services Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Pharmaceutical Serialisation Services Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Pharmaceutical Serialisation Services Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Pharmaceutical Serialisation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Pharmaceutical Serialisation Services Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Pharmaceutical Serialisation Services Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Pharmaceutical Serialisation Services Image Figure 2. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Serialisation Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Barcode Image Figure 5. QR Code Image Figure 6. RFID Image Figure 7. Others Image Figure 8. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pharmaceutical Serialisation Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Manufacturing Image Figure 11. Pharmaceutical Distribution Image Figure 12. Pharmaceutical Logistics Image Figure 13. Global Pharmaceutical Serialisation Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Pharmaceutical Serialisation Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Serialisation Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Serialisation Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pharmaceutical Serialisation Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Serialisation Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Serialisation Services Revenue Market Share by Type (2021-2032) Figure 21. Global Pharmaceutical Serialisation Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical Serialisation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032) Figure 26. North America Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032) Figure 27. North America Pharmaceutical Serialisation Services Revenue Share by Country (2021-2032) Figure 28. United States Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Pharmaceutical Serialisation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032) Figure 33. Europe Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032) Figure 34. Europe Pharmaceutical Serialisation Services Revenue Share by Country (2021-2032) Figure 35. Germany Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Pharmaceutical Serialisation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032) Figure 45. China Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032) Figure 46. Asia Pharmaceutical Serialisation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032) Figure 48. Asia Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032) Figure 49. Asia Pharmaceutical Serialisation Services Revenue Share by Region (2021-2032) Figure 50. Japan Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Pharmaceutical Serialisation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Pharmaceutical Serialisation Services Revenue Share by Country (2021-2032) Figure 60. Brazil Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Pharmaceutical Serialisation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Barcode
  • QR Code
  • RFID
  • Others
Applications
  • Pharmaceutical Manufacturing
  • Pharmaceutical Distribution
  • Pharmaceutical Logistics
Companies covered
  • Movianto
  • UPM Pharmaceuticals
  • MSK Pharmalogisti
  • Covectra
  • Koerber-Pharma
  • Palladio Group
  • TraceLink
  • Ultimate Solutions
  • Clarkston Consulting
  • Jones Healthcare Group
  • MSK Pharmalogistic
  • Vetter-Pharma
  • NextPharma Logistics
  • OPTEL
  • Central Pharma
  • Aphena Pharma +C581Solutions
  • NNE
  • Sharp Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Serialisation Services Market by Type
  3. 1.2.1 Global Pharmaceutical Serialisation Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Barcode
  5. 1.2.3 QR Code
  6. 1.2.4 RFID
  7. 1.2.5 Others
  8. 1.3 Pharmaceutical Serialisation Services Market by Application
  9. 1.3.1 Global Pharmaceutical Serialisation Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Manufacturing
  11. 1.3.3 Pharmaceutical Distribution
  12. 1.3.4 Pharmaceutical Logistics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pharmaceutical Serialisation Services Market Dynamics
  1. 2.1 Pharmaceutical Serialisation Services Industry Trends
  2. 2.2 Pharmaceutical Serialisation Services Industry Drivers
  3. 2.3 Pharmaceutical Serialisation Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Serialisation Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Serialisation Services Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Serialisation Services Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Serialisation Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Serialisation Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Serialisation Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Serialisation Services Revenue by Players
  2. 4.1.1 Global Pharmaceutical Serialisation Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Serialisation Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Serialisation Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Serialisation Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Serialisation Services Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Serialisation Services Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Serialisation Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Serialisation Services Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Serialisation Services Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Serialisation Services Market Size by Type
  1. 5.1 Global Pharmaceutical Serialisation Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Serialisation Services Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Serialisation Services Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Serialisation Services Market Size by Application
  1. 6.1 Global Pharmaceutical Serialisation Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Serialisation Services Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Movianto
  2. 7.1.1 Movianto Company Information
  3. 7.1.2 Movianto Business Overview
  4. 7.1.3 Movianto Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Movianto Pharmaceutical Serialisation Services Product Portfolio
  6. 7.1.5 Movianto Recent Developments
  7. 7.2 UPM Pharmaceuticals
  8. 7.2.1 UPM Pharmaceuticals Company Information
  9. 7.2.2 UPM Pharmaceuticals Business Overview
  10. 7.2.3 UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio
  12. 7.2.5 UPM Pharmaceuticals Recent Developments
  13. 7.3 MSK Pharmalogisti
  14. 7.3.1 MSK Pharmalogisti Company Information
  15. 7.3.2 MSK Pharmalogisti Business Overview
  16. 7.3.3 MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio
  18. 7.3.5 MSK Pharmalogisti Recent Developments
  19. 7.4 Covectra
  20. 7.4.1 Covectra Company Information
  21. 7.4.2 Covectra Business Overview
  22. 7.4.3 Covectra Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Covectra Pharmaceutical Serialisation Services Product Portfolio
  24. 7.4.5 Covectra Recent Developments
  25. 7.5 Koerber-Pharma
  26. 7.5.1 Koerber-Pharma Company Information
  27. 7.5.2 Koerber-Pharma Business Overview
  28. 7.5.3 Koerber-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio
  30. 7.5.5 Koerber-Pharma Recent Developments
  31. 7.6 Palladio Group
  32. 7.6.1 Palladio Group Company Information
  33. 7.6.2 Palladio Group Business Overview
  34. 7.6.3 Palladio Group Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Palladio Group Pharmaceutical Serialisation Services Product Portfolio
  36. 7.6.5 Palladio Group Recent Developments
  37. 7.7 TraceLink
  38. 7.7.1 TraceLink Company Information
  39. 7.7.2 TraceLink Business Overview
  40. 7.7.3 TraceLink Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 TraceLink Pharmaceutical Serialisation Services Product Portfolio
  42. 7.7.5 TraceLink Recent Developments
  43. 7.8 Ultimate Solutions
  44. 7.8.1 Ultimate Solutions Company Information
  45. 7.8.2 Ultimate Solutions Business Overview
  46. 7.8.3 Ultimate Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio
  48. 7.8.5 Ultimate Solutions Recent Developments
  49. 7.9 Clarkston Consulting
  50. 7.9.1 Clarkston Consulting Company Information
  51. 7.9.2 Clarkston Consulting Business Overview
  52. 7.9.3 Clarkston Consulting Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio
  54. 7.9.5 Clarkston Consulting Recent Developments
  55. 7.10 Jones Healthcare Group
  56. 7.10.1 Jones Healthcare Group Company Information
  57. 7.10.2 Jones Healthcare Group Business Overview
  58. 7.10.3 Jones Healthcare Group Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio
  60. 7.10.5 Jones Healthcare Group Recent Developments
  61. 7.11 MSK Pharmalogistic
  62. 7.11.1 MSK Pharmalogistic Company Information
  63. 7.11.2 MSK Pharmalogistic Business Overview
  64. 7.11.3 MSK Pharmalogistic Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio
  66. 7.11.5 MSK Pharmalogistic Recent Developments
  67. 7.12 Vetter-Pharma
  68. 7.12.1 Vetter-Pharma Company Information
  69. 7.12.2 Vetter-Pharma Business Overview
  70. 7.12.3 Vetter-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio
  72. 7.12.5 Vetter-Pharma Recent Developments
  73. 7.13 NextPharma Logistics
  74. 7.13.1 NextPharma Logistics Company Information
  75. 7.13.2 NextPharma Logistics Business Overview
  76. 7.13.3 NextPharma Logistics Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio
  78. 7.13.5 NextPharma Logistics Recent Developments
  79. 7.14 OPTEL
  80. 7.14.1 OPTEL Company Information
  81. 7.14.2 OPTEL Business Overview
  82. 7.14.3 OPTEL Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 OPTEL Pharmaceutical Serialisation Services Product Portfolio
  84. 7.14.5 OPTEL Recent Developments
  85. 7.15 Central Pharma
  86. 7.15.1 Central Pharma Company Information
  87. 7.15.2 Central Pharma Business Overview
  88. 7.15.3 Central Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Central Pharma Pharmaceutical Serialisation Services Product Portfolio
  90. 7.15.5 Central Pharma Recent Developments
  91. 7.16 Aphena Pharma +C581Solutions
  92. 7.16.1 Aphena Pharma +C581Solutions Company Information
  93. 7.16.2 Aphena Pharma +C581Solutions Business Overview
  94. 7.16.3 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio
  96. 7.16.5 Aphena Pharma +C581Solutions Recent Developments
  97. 7.17 NNE
  98. 7.17.1 NNE Company Information
  99. 7.17.2 NNE Business Overview
  100. 7.17.3 NNE Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 NNE Pharmaceutical Serialisation Services Product Portfolio
  102. 7.17.5 NNE Recent Developments
  103. 7.18 Sharp Services
  104. 7.18.1 Sharp Services Company Information
  105. 7.18.2 Sharp Services Business Overview
  106. 7.18.3 Sharp Services Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Sharp Services Pharmaceutical Serialisation Services Product Portfolio
  108. 7.18.5 Sharp Services Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Serialisation Services Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Serialisation Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Serialisation Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Serialisation Services Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Serialisation Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Serialisation Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Serialisation Services Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Serialisation Services Revenue by Country
  11. 8.6.1 North America Pharmaceutical Serialisation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Serialisation Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Serialisation Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Serialisation Services Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Serialisation Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Serialisation Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Serialisation Services Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Serialisation Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Serialisation Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Serialisation Services Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Serialisation Services Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Serialisation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Serialisation Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Serialisation Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Serialisation Services Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Serialisation Services Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Serialisation Services Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Serialisation Services Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Serialisation Services Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Serialisation Services Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Serialisation Services Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Serialisation Services Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Serialisation Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Serialisation Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Serialisation Services Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Serialisation Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Serialisation Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Serialisation Services Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Serialisation Services Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Serialisation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Serialisation Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Serialisation Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Serialisation Services Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Serialisation Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Serialisation Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Serialisation Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Serialisation Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Serialisation Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Serialisation Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Serialisation Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Serialisation Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Serialisation Services Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Serialisation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Serialisation Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Serialisation Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst